title: Evaluation of Hydro ThermAblator for endometrial destruction in patients with menorrhagia.
abstract: OBJECTIVE
  To describe endometrial destruction with the Hydro ThermAblator.
  
  
  METHODS
  (Canadian Task Force classification II-1).
  
  
  METHODS
  University-affiliated hospital.
  
  
  METHODS
  Twenty-six women with uncontrolled menorrhagia.
  
  
  METHODS
  Endometrial ablation with saline heated to 90 degrees C and circulated in the uterine cavity for 10 minutes under hysteroscopic control.
  
  
  RESULTS
  All patients tolerated the procedure well, all but one was satisfied with the results, and there were no significant side effects or complications. Seventy-seven percent of women were either amenorrheic or hypomenorrheic after 6 months, and 88% were amenorrheic or hypomenorrheic after 1 year, including one patient who was treated a second time; 87.5% were amenorrheic or hypomenorrheic at 18 months. One woman had persistent menorrhagia and was treated by hysterectomy.
  
  
  CONCLUSIONS
  In this study, endometrial ablation was performed successfully with the Hydro ThermAblator in 25 of 26 women. (J Am Assoc Gynecol Laparosc 6(3):275-278, 1999)
authors.affiliation: Research Institute of Gynecology and Oncology, Sao Paulo, Brazil.
authors.forename: G B
authors.initials: GB
authors.lastname: das Dores
authors.forename: R M
authors.initials: RM
authors.lastname: Richart
authors.forename: S M
authors.initials: SM
authors.lastname: Nicolau
authors.forename: G R
authors.initials: GR
authors.lastname: Focchi
authors.forename: V C
authors.initials: VC
authors.lastname: Cordeiro
mesh_terms: D000328:Adult; D017115:Catheter Ablation / Q000295:instrumentation* / Q000379:methods; D004717:Endometrium / Q000601:surgery*; D004867:Equipment Design; D004869:Equipment Safety; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015907:Hysteroscopy / Q000379:methods; D008595:Menorrhagia / Q000175:diagnosis / Q000601:surgery*; D008875:Middle Aged; D012965:Sodium Chloride / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D012965:Sodium Chloride